Skip to main content

Bamlanivimab / etesevimab for COVID-19 User Reviews

Brand names: bamlanivimab and etesevimab

  • Covid
  • Taken for less than 1 month
  • July 29, 2022

Bamlanivimab and etesevimab (bamlanivimab / etesevimab) "I was on day 7 of Covid with mild symptoms and 2 hours after I received the monoclonals my heart rate spiked and I went to the hospital. I had a massive inflammatory response. I developed pericarditis and Costochondritis. It’s now 7 months later and I am still having significant heart problems and now have heart disease."

1 / 10
Was this helpful?YesNo
2 Report

Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.

Learn more about COVID-19

Care guides

Medicine.com guides (external)

More about bamlanivimab / etesevimab

Patient resources

Other brands

bamlanivimab and etesevimab

Professional resources

Other brands

bamlanivimab and etesevimab

Related treatment guides